Abstract:Objective To investigate the antibiotic resistance of extended-spectrum-β-1actamases (ESBLs)-producing Escherichia coli (E.coli) and Klebsiella pneumoniae (K.pneumoniae) isolates and the risk factors of bloodstream infections caused by these strains.Methods Clinical data of 131 patients with E.coli or K.pneumoniae-induced bloodstream infections admitted in the Second Affiliated Hospital of Zhejiang Chinese Medical University during September 2009 and June 2014 were retrospectively analyzed.Species identification and antimicrobial susceptibility test were performed by Vitek 2 system,and ESBLs production was tested by standard disk diffusion method.Logistic regression analysis was performed to identify the risk factors of bloodstream infections induced by ESBLs-producing strains.Results Among 131 patients,65 were infected with ESBLs-producing strains,and 66 were infected with non-ESBLs-producing strains.The resistance rates of ESBLs-producing strains were above 50％ for penicillin,aztreonam and third/fourth generation cephalosporins,which were significantly higher than those of non-ESBLs producing strains.The resistance rates of ESBLs-producing E.coli and K.pneumoniae to carbapenems and piperacillin/tazobactam were 0-2.0％,2.3％ and 0-14.3％,26.7％,respectively.The univariate analysis revealed that patients with exposure to cephalosporins in recent 3 months (x2 =18.322,P ＜ 0.01),prior infection with ESBLs-producing strains (x2=14.610,P＜0.01),indwelling catheter in recent 3 months (x2 =13.016,P ＜ 0.01),history of hospitalization in recent 3 months (x2 =11.269,P ＜ 0.01),exposure to quinolones in recent 3 months (x2 =10.638,P ＜ 0.01),nosocomial infection (x2 =8.205,P ＜ 0.01),history of indwelling deep venous catheter or percutaneous central catheter in recent 3 months (x2 =4.817,P ＜ 0.05) and exposure to glucocorticoid hormone in recent 3 months (x2 =4.265,P ＜ 0.05) were associated with infection of ESBLs-producing strains.Multivariate Logistic regression analysis revealed that exposure to quinolones in recent 3 months (OR =6.851,P ＜ 0.01),prior infection with ESBLs-producing strains (OR =6.344,P ＜ 0.01),exposure to cephalosporins in recent 3 months (OR =3.719,P ＜ 0.01),and indwelling catheter in recent 3 months (OR =3.180,P ＜ 0.05) were independent risk factors for ESBLs-producing E.coli or K.pneumoniae infection.Conclusions ESBLs-producing E.coli or K.pneumoniae isolates are highly resistant to most antibiotics,and multidrug-resistance is common.Carbapenems were still the most effective antibiotics against ESBLs-producing E.coli or K.pneumoniae infection.Rational use of cephalosporins and quinolones,strictly following aseptic technique in operation,strict use of indications for indwelling catheterization,and completely eradicating ESBLs-producing strains in previous infections may be helpful in reducing bloodstream infections by ESBLs-producing E.coli or K.pneumoniae.

Detection, identification of ESBL and antibacterial susceptibility test of ESBL-producing strains

Study on Antibiotics Resistance of Extended-Spectrum Β-Lactamases-producing Escherichia Coil and Klebsiella Pneumoniae in Hangzhou

Antibiotic resistance of ESBLs-producing Escherichia coli and Klebsiella pneumoniae isolates and risk factors for bloodstream infections

Study on the epidemiology and β-lactamase-encoding genes of multiple-drug-resistant klebsiella pneumoniae

Molecular Epidemiologic Study of Extended-Spectrum Beta-Lactamase in Escherichia Coli and Klebsiella Pnenmoniae

Detection of extended-spectrum β-lactamases and drug sensitivity test of Klebsiella pneumoniae and Escherichia coli in lower respiratory tract specimens

Distribution of extended spectrum β-lactamase producing strains and their antibiotics resistance

Detection of ESBLs- producing strains in Enterobacteriaceae and the analysis of its susceptibility testing

Surveillance of Lower Respiratory Tract Infection of ESBL-producing Strains and Analysis of Risk Factors for Acquisition

[Extended-Spectrum Beta-Lactamase in Klebsiella Pneumoniae and Escherichia Coli Isolates].

Detection and Analysis on Resistance of Superspectrum Beta-Lactamases in E. Coli, Klebsiella Spp and P. Mirabilis Isolates.

Study of the best detection substrate and antibiotic resistance in clinical of Escherichia coli and klebsieua pneumoniae producing extended-spectrum beta-lactamases

Detection of Producing Extended-Spectrum Β-Lactamases (esbls) and the Analysis of Drug Susceptivity

Resistance of Strains Producing Extended-Spectrum Β-Lactamases and Genotype Distribution in China

Detection of drug resistance and genotype of extended-spectrum β-lactamase producing Enterobacteriaceae bacteria

The Prevalence of Extended-Spectrum Β-Lactamase and the Analysis of Antibiotic Susceptibility in Clinical Escherichia Coli Isolates

Prevalence and Antimicrobial Resistance of Extended-Spectrum Β-Lactamases Producing Klebsiella Pneumonia

Identification, Antibacterial Susceptibility and Gene Typing of Clinical ESBLs-producing Bacteria

Epidemiology and Antimicrobial Susceptibility Profiles of Extended-Spectrum Beta-Lactamase–producing Klebsiella Pneumoniae and Escherichiacoli in China

Detection of AmpC and Extended Spectrum Β-Lactamases in Escherichia Coli and Klebslella Pneumoniae and Analysis of Resistance

Clinical analysis of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases in patients with respiratory tract infection